Annual Results Results Snapshot
Figures in Cr
Consolidate Annual Results
Mar'26
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Mar'20
Net Sales
503.08
370.20
307.17
251.03
456.19
262.01
139.30
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
503.08
370.20
307.17
251.03
456.19
262.01
139.30
Raw Material Cost
240.81
165.41
153.81
113.22
199.31
165.28
91.92
Purchase of Finished goods
17.35
15.90
0.85
0.04
3.80
0.22
0.67
(Increase) / Decrease In Stocks
0.28
1.17
-1.48
-3.20
-2.51
0.09
-5.51
Employee Cost
54.04
43.78
32.56
29.96
20.15
15.90
11.93
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
-0.01
0.01
0.00
0.01
0.00
0.00
0.00
Selling and Distribution Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Expenses
72.37
63.54
55.12
50.86
63.77
51.68
26.10
Total Expenditure (Excl Depreciation)
384.84
289.81
240.86
190.89
284.52
233.17
125.11
Operating Profit (PBDIT) excl Other Income
118.24
80.39
66.31
60.14
171.67
28.84
14.19
Other Income
2.86
1.92
1.83
2.94
3.51
1.59
3.66
Operating Profit (PBDIT)
121.10
82.31
68.14
63.08
175.18
30.43
17.85
Interest
10.97
9.88
10.39
6.02
2.92
2.67
2.50
Exceptional Items
-0.83
0.00
-7.10
-16.53
0.00
0.00
0.00
Gross Profit (PBDT)
109.30
72.43
50.65
40.53
172.26
27.76
15.35
Depreciation
19.81
18.29
19.56
14.96
10.69
6.49
4.43
Profit Before Tax
89.49
54.14
31.10
25.57
161.57
21.27
10.92
Tax
22.15
14.34
7.48
6.29
41.63
6.38
2.71
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
67.35
39.80
23.62
19.28
119.94
14.89
8.21
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
67.35
39.80
23.62
19.28
119.94
14.89
8.21
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
0.00
0.04
0.18
0.09
0.05
0.26
0.11
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
67.35
39.85
23.80
19.37
119.99
15.15
8.32
Equity Capital
10.38
10.38
10.38
10.38
10.38
10.38
10.38
Face Value
10.0
10.0
10.0
10.0
10.0
10.0
10.0
Reserves
320.42
252.87
213.04
189.34
170.77
50.78
35.63
Earnings per share (EPS)
64.88
38.39
22.93
18.66
115.6
14.6
8.02
Diluted Earnings per share
64.9
38.36
22.76
18.16
115.64
14.6
8.02
Operating Profit Margin (Excl OI)
23.5%
21.72%
21.59%
23.96%
37.63%
11.01%
10.19%
Gross Profit Margin
21.73%
19.57%
16.49%
16.15%
37.76%
10.6%
11.02%
PAT Margin
13.39%
10.75%
7.69%
7.68%
26.29%
5.68%
5.89%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Annual Analysis Highlights
Net Sales
YoY Growth in year ended Mar 2026 is 35.89% vs 20.52% in Mar 2025
Consolidate Net Profit
YoY Growth in year ended Mar 2026 is 69.01% vs 67.44% in Mar 2025
Operating Profit (PBDIT) excl Other Income
YoY Growth in year ended Mar 2026 is 47.08% vs 21.23% in Mar 2025
Interest
YoY Growth in year ended Mar 2026 is 11.03% vs -4.91% in Mar 2025
Operating Profit Margin (Excl OI)
YoY Growth in year ended Mar 2026 has improved from Mar 2025
Compare Annual Results Of Kwality Pharma With
Figures in Cr
Consolidate Annual Results
Change(INR)
Change(%)
Net Sales
503.08
1,845.32
-1,342.24
-72.74%
Other Operating Income
0.00
0.00
0.00
Total Operating income
503.08
1,845.32
-1,342.24
-72.74%
Raw Material Cost
240.81
425.60
-184.79
-43.42%
Purchase of Finished goods
17.35
143.55
-126.20
-87.91%
(Increase) / Decrease In Stocks
0.28
-27.41
27.69
101.02%
Employee Cost
54.04
425.69
-371.65
-87.31%
Power Cost
0.00
0.00
0.00
Manufacturing Expenses
-0.01
0.00
-0.01
Selling and Distribution Expenses
0.00
79.54
-79.54
-100.00%
Other Expenses
72.37
656.55
-584.18
-88.98%
Total Expenditure (Excl Depreciation)
384.84
1,703.52
-1,318.68
-77.41%
Operating Profit (PBDIT) excl Other Income
118.24
141.80
-23.56
-16.61%
Other Income
2.86
3.33
-0.47
-14.11%
Operating Profit (PBDIT)
121.10
145.13
-24.03
-16.56%
Interest
10.97
122.25
-111.28
-91.03%
Exceptional Items
-0.83
-2.94
2.11
71.77%
Gross Profit (PBDT)
109.30
19.94
89.36
448.14%
Depreciation
19.81
126.45
-106.64
-84.33%
Profit Before Tax
89.49
-106.51
196.00
184.02%
Tax
22.15
-7.81
29.96
383.61%
Provisions and contingencies
0.00
0.00
0.00
Profit After Tax
67.35
-98.70
166.05
168.24%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
Net Profit
67.35
-98.70
166.05
168.24%
Share in Profit of Associates
0.00
0.00
0.00
Minority Interest
0.00
3.55
-3.55
-100.00%
Other related items
0.00
0.00
0.00
Consolidated Net Profit
67.35
-95.15
162.50
170.78%
Equity Capital
10.38
18.46
-8.08
-43.77%
Face Value
10.00
2.00
0.00
Reserves
320.42
920.82
-600.40
-65.20%
Earnings per share (EPS)
64.88
-10.31
75.19
729.29%
Diluted Earnings per share
64.90
-10.69
75.59
707.11%
Operating Profit Margin (Excl OI)
23.50%
7.91%
0.00
15.59%
Gross Profit Margin
21.73%
1.11%
0.00
20.62%
PAT Margin
13.39%
-5.50%
0.00
18.89%
Public Share Holdings (%)
0.00%
0.00%
0.00
0.00%
Pledged Promotor Holding (%)
0.00%
0.00%
0.00
0.00%
Annual - Net Sales
Net Sales 503.08 Cr
in Mar 2026Figures in Cr
YoY Growth in year ended Mar 2026 is 35.89% vs 20.52% in Mar 2025
Annual - Consolidate Net Profit
Consolidate Net Profit 67.35 Cr
in Mar 2026Figures in Cr
YoY Growth in year ended Mar 2026 is 69.01% vs 67.44% in Mar 2025
Annual - Operating Profit (PBDIT)
Operating Profit (PBDIT) 118.24 Cr
in Mar 2026Figures in Cr
YoY Growth in year ended Mar 2026 is 47.08% vs 21.23% in Mar 2025
Annual - Interest
Interest 10.97 Cr
in Mar 2026Figures in Cr
YoY Growth in year ended Mar 2026 is 11.03% vs -4.91% in Mar 2025
Annual - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 23.50%
in Mar 2026Figures in %
YoY Growth in year ended Mar 2026 has improved from Mar 2025
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
